Raptor Pharmaceutical Corp Finite-Lived Intangible Asset, Expected Amortization, Year Five
Raptor Pharmaceutical Corp had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $529.00 thousand as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2016-08-04
- 2016-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $529.00K.
- 2016-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $529.00K.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $529.00K.
- 2015-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $238.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2016-06-30 | $529.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $529.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $529.00K 10-K · filed 2016-02-26 |
| 2015-09-30 | $238.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $238.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $238.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $238.00K 10-K · filed 2015-03-02 |
| 2014-09-30 | $238.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $238.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $238.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $238.00K 10-K · filed 2014-03-17 |
| 2013-09-30 | $238.00K 10-Q/A · filed 2014-05-12 |
| 2013-06-30 | $201.00K 10-Q/A · filed 2014-05-12 |
| 2013-03-31 | $146.00K 10-Q/A · filed 2014-05-12 |
| 2012-12-31 | $146.00K 10-KT/A · filed 2014-05-12 |
| 2012-11-30 | $146.00K 10-Q · filed 2013-01-09 |
| 2012-08-31 | $146.00K 10-K · filed 2012-11-14 |